Market Research Report
Global Western Blotting Processors Market - 2020-2027
|Published by||DataM Intelligence||Product code||990446|
|Published||Pre-Order||Content info||180 Pages
Delivery time: 2 business days
|Global Western Blotting Processors Market - 2020-2027|
|Published: Pre-Order||Content info: 180 Pages||
The western blotting is referred to an analytical technique used to separate and detect specific proteins on the basis of relative molecular mass of proteins. Western blotting processors are devices used to do western blotting techniques to attain high sensitivity and specificity facilitating detection of preferred protein with a concentration nearly ten times lesser than the threshold of detection. The results attained with the conventional western blotting processors are relatively unreliable, tedious and require technical expertise which is addressed by the automated western blot processors.
The global western blotting processors market size was worth US$ XX billion in 2019 and further predicted to reach US$ XX billion by 2027, at a CAGR of XX% during the forecast period (2020-2027).
Certain factors that are leading the market growth include the increasing prevalence of HIV/AIDS, the increasing R&D expenditure by pharmaceutical and biotechnology companies, and untapped opportunities in the emerging markets. However, the emergence of alternative technologies will hamper the market growth during the forecast period.
Rising adoption of western blotting processor in increasing proteomics research
The market for western blotting processor is considerably driven by the proteomics and genomics research. Proteomics approaches includes the characterization and identification of post-translational modifications, protein-protein interaction, protein turnovers, and more. With the rising focus on the development of efficient personalized medicine, the demand for western blotting processor is increasing globally.
Increasing focus on personalized medicine
The increasing adoption of personalized medicines for cancer is augmenting the adoption of western blotting processors. Personalized medicine has the potential to provide the best response and highest safety margin to ensure better patient care. Personalized medicine has the potential to improve several aspects of healthcare while lowering costs, which is expected to be a positive indicator for growth of the market. According to Personalized Medicine Coalition, biopharmaceutical researchers predict a 69% increase in the number of personalized medicines in the development over the next five years.
COVID-19 Impact Analysis
A increase in the market value of western blotting processors is expected in 2020, backed by application of western blotting processor in COVID-19. Therefore, the demand for western blotting processors increased amid the COVID-19 pandemic, which in turn, increased its sales in 2020.
Based on the application, the western blotting processors market has been classified into biomedical & biochemical research, disease diagnostics, agriculture, and others.
Disease diagnostics segment contributed significant share to the global western blotting processors market in 2019
Disease diagnostics dominated the western blotting processor market in 2019. This is due to a rise in the increasing incidences of target diseases, such as Hepatitis and Lyme disease across the globe. Moreover, the use of these devices to identify specific protein molecules from a mixture of protein samples in proteomics and genetic science are certain key factors expected to drive the market growth in the forecast period.
Based on the end-user, the western blotting processors market has been classified into academic & research institutes, pharmaceutical & biotechnology companies, diagnostic centers, and others.
Academic & research institutes lead the market throughout the forecast period
Academic & research institutes segment led the overall market with a share in 2019. A number of research activities ongoing in the academic & research laboratories is augmenting the demand for western blotting processors. The majorly demand is driven across the developed and emerging nations, such as the US, UK, Germany.
Based on geography, the study analyzes the western blotting processors market in the global market, including North America, South America, Europe, Asia-Pacific, and the Middle East & Africa.
North America leads the global market throughout the forecast period
North America dominated the global western blotting processors market with the largest share in terms of value and volume globally, followed by Europe and the Asia Pacific. The US dominated the North American western blotting processors market in 2019. This is owing to the increasing prevalence of Lyme disease and HIV, and the rise in research funding and growing production of genetically modified crops, and rising number of research conferences. Moreover, Asia Pacific is expected to project the fastest growth rate in the western blotting processors market during the forecast period. China dominates the market, whereas India is estimated to exhibit considerable growth in the Asia Pacific western blotting processors market during the forecast period.
The western blotting processors market is highly competitive, owing to the large presence of western blotting processors brands. The key western blotting processors players include Bio-Rad Laboratories, Inc., Cell Signaling Technology, Advansta Inc., Li-Cor Biosciences, Bio-Techne Corporation, GE Healthcare, Cytoskeleton Inc., PerkinElmer Inc., F. Hoffmann-La Roche Ltd., Merck KGaA The crucial players are adopting new product launches and expansion strategies for global growth in the western blotting processors market.
F. Hoffmann-La Roche Ltd.
Overview: F. Hoffmann-La Roche Ltd. was incorporated in 1896 and is headquartered in Switzerland. The company has 29 R&D sites and 23 manufacturing sites for Pharmaceuticals, and Diagnostics segment with over 97,700 employees across the globe. Roche's operating businesses are organized into two divisions- Pharmaceuticals and Diagnostics.
Product Portfolio: The company's portfolio comprises Lumi-LightPLUS Western Blotting Substrate.
The global western blotting processors market report would provide access to an approx. 54 market data tables, 54 figures, and 262 pages.
LIST NOT EXHAUSTIVE